entertainment -WSS

entertainment

author：entertainment 2025-09-14 10:02:03 - browse：7

A DNA helix, with dollar banknotes covering its strands, collapses next to another DNA helix with dollar banknotes strands — coverage from STAT — Adobe

The closely watched gene-editing startup Prime Medicine is embroiled in a multimillion-dollar dispute with another biotech it partnered with to develop a potentially powerful new form of genome editing.

Prime and Myeloid Therapeutics, a startup co-founded by Pulitzer Prize-winning writer and cancer biologist Siddhartha Mukherjee, have filed competing arbitration claims over a deal they signed in March 2022.

Prime, spun out of the lab of Broad Institute biochemist David Liu, was built on technology for making small insertions, deletions, and single-letter changes in DNA. In theory, prime editing allows researchers to tackle the vast majority of disease-causing mutations, and the first treatments are already being readied for clinical trials. But it’s a poor fit in cases where hundreds or even thousands of different mutations in a long gene cause the same diseases, such as cystic fibrosis or Duchenne muscular dystrophy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Novo Nordisk touts Wegovy study, but still struggling with supply

explore

WSS

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

10 states plan to sue EPA over standards for residential wood

Treatments for cramps don't cut it. Why aren't there better options?

Treatments for cramps don't cut it. Why aren't there better options?

EU climate chief is concerned over the expansion of the coal industry in China

Judge sides with young activists in first

entertainment

entertainment

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

Jerome Adams on the need for new antivirals for Covid

Bird flu researchers hone in on Finland’s mink farms

Anesthesiologist group: stop taking Ozempic before surgery

Noem? Reynolds? A very early look at the Republican 'veepstakes'

At least 13 dead in Texas as scorching temps continue

Timeline: How the deadly wildfires took over Maui day by day

Moonlake's readout produced a cash windfall. Risks remain

Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

focus

Elon Musk announces 'temporary limits' for reading Twitter posts

Megan Rapinoe shares emotional post following US Women's World Cup exit

Maui wildfire now ranks as the fifth

Surge in Apellis stock fueled by confidence in safety of its eye drug

What to know about the judge who will handle the Trump case

10 states plan to sue EPA over standards for residential wood

hotspot

explore

hotspot

leisure time